SCHEMBL5019788

SCHEMBL5019788

O=c1c2cc(-c3cc(-c4ccccc4)cc(-c4ccccc4)c3)ccc2sc2ccc(-c3cc(-c4ccccc4)cc(-c4ccccc4)c3)cc12

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.50
RAB9A P51151 3/20 0.46
NPC1 O15118 2/20 0.46
MAPT P10636 2/20 0.46
L3MBTL1 Q9Y468 2/20 0.46
ALDH1A1 P00352 2/20 0.46
TDP1 Q9NUW8 1/20 0.46
LIMK1 P53667 1/20 0.44
PIM3 Q86V86 2/20 0.43
PIM1 P11309 1/20 0.41
PIM2 Q9P1W9 1/20 0.41
PTPN1 P18031 2/20 0.40
PTPN2 P17706 1/20 0.40
MAOA P21397 1/20 0.39
MAOB P27338 1/20 0.39
LMNA P02545 2/20 0.39
MEN1 O00255 1/20 0.39
APAF1 O14727 1/20 0.39
THRB P10828 1/20 0.39
XBP1 P17861 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5019911 1.00 KDM4E (0.50) KDM4ERAB9ANPC1MAPTL3MBTL1
SCHEMBL5019862 0.96 KDM4E (0.50) KDM4ERAB9ANPC1MAPTL3MBTL1
SCHEMBL5019863 0.96 KDM4E (0.53) KDM4ERAB9ANPC1MAPTL3MBTL1
SCHEMBL5019864 0.96 KDM4E (0.53) KDM4ERAB9ANPC1MAPTL3MBTL1
SCHEMBL5019905 0.93 KDM4E (0.57) KDM4ERAB9ANPC1MAPTL3MBTL1
SCHEMBL22171902 0.91 KDM4E (0.58) KDM4ERAB9ANPC1MAPTL3MBTL1
SCHEMBL1614826 0.91 KDM4E (0.62) KDM4ERAB9ANPC1MAPTL3MBTL1
SCHEMBL29397550 0.91 KDM4E (0.62) KDM4ERAB9ANPC1MAPTL3MBTL1
SCHEMBL22172013 0.91 KDM4E (0.62) KDM4ERAB9ANPC1MAPTL3MBTL1
SCHEMBL5019910 0.90 KDM4E (0.49) KDM4ERAB9ANPC1MAPTL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230139115-A1 ORGANIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE CANON KABUSHIKI KAISHA (JP) 2023-05-04 US disclosed
US-20230139115-A1 ORGANIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE CANON KABUSHIKI KAISHA (JP) 2023-05-04 US disclosed
US-20230050869-A1 THERMOELECTRIC CONVERSION MATERIAL, AND THERMOELECTRIC CONVERSION ELEMENT PREPARED THEREWITH TOYO INK SC HOLDINGS CO., LTD. (JP) 2023-02-16 US disclosed
EP-3902021-A1 THERMOELECTRIC CONVERSION MATERIAL, AND THERMOELECTRIC CONVERSION ELEMENT PREPARED THEREWITH Toyo Ink SC Holdings Co., Ltd. (JP) 2021-10-27 EP disclosed
US-8952367-B2 Thioxanthone compound and organic light emitting element having the same CANON KABUSHIKI KAISHA (JP) 2015-02-10 US disclosed
US-8952367-B2 Thioxanthone compound and organic light emitting element having the same CANON KABUSHIKI KAISHA (JP) 2015-02-10 US disclosed
US-20130221340-A1 THIOXANTHONE COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT HAVING THE SAME CANON KABUSHIKI KAISHA (JP) 2013-08-29 US disclosed
US-20130221340-A1 THIOXANTHONE COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT HAVING THE SAME CANON KABUSHIKI KAISHA (JP) 2013-08-29 US disclosed
WO-2012063751-A1 THIOXANTHONE COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT HAVING THE SAME CANON KABUSHIKI KAISHA (JP) 2012-05-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230139115-A1 ORGANIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE OR10J3, MLX, RPS4X KDM4E 3145/4885RAB9A 3297/4885NPC1 2735/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.